腋臭芍倍注射术后脂膜炎一例  

A case of axillary osmidrosis developing panniculitis after Shaobei injection

作　　者：苏俊秀 徐屹 康旭[2] Su Junxiu;Xu Yi;Kang Xu(The Second Clinical Medical School,Guangzhou University of Chinese Medicine,Guangzhou 510006,China;不详)

机构地区：[1]广州中医药大学第二临床医学院,广州510006 [2]中医药大学第二附属医院(广东省中医院)皮肤科,广州510120

出　　处：《新医学》2022年第6期461-464,共4页Journal of New Medicine

摘　　要：芍倍注射液是一种软化萎缩剂,可用于治疗腋臭,不良反应极少。脂膜炎是累及皮下脂肪层的一类皮肤病。该文报道1例接受芍倍注射术后继发脂膜炎的病例。该例为37岁女性,接受了双侧腋窝芍倍注射术,术后8 d左侧腋窝出现皮下结节,并伴有疼痛,后皮下脂肪发生液化坏死,经切开引流后痊愈,病灶处皮下组织病理学检查示变性坏死的纤维脂肪组织,确诊为脂膜炎。该例提示,虽然芍倍注射液的不良反应极少,但在被用于治疗腋臭时仍有可能引发脂膜炎,芍倍注射术后继发脂膜炎时应充分引流,及时清除病灶。Shaobei injection is a softening and shrinking agent,which is applied to treat axillary osmidrosis and rarely causes adverse reactions.Panniculitis is a skin disease that involves the subcutaneous fat layer.In this article,one case of panniculitis secondary to Shaobei injection was reported.The 37-year-old female patient developed left-sided subcutaneous nodules complicated with pain at 8 d after Shaobei injection.Subsequently,subcutaneous fat liquefaction and necrosis occurred,which were recovered after incision and drainage.Pathological examination of subcutaneous tissues of the lesions displayed degeneration and necrosis of fibrous adipose tissues.The patient was diagnosed with panniculitis.This case prompts that although Shaobei injection rarely yields adverse reactions,it might lead to panniculitis.For patients developing panniculitis post-Shaobei injection,incision and drainage should be performed to promptly eliminate the lesions.

关 键 词：腋臭 芍倍注射液 脂膜炎 

分 类 号：R758.741[医药卫生—皮肤病学与性病学]